US2015152375A1PendingUtilityA1

Systems and methods for isolating and using clinically safe adipose derived regenerative cells

Assignee: CYTORI THERAPEUTICS INCPriority: Dec 7, 2001Filed: Nov 10, 2014Published: Jun 4, 2015
Est. expiryDec 7, 2021(expired)· nominal 20-yr term from priority
C12M 29/04C12N 5/0667C12M 45/00A61K 35/28A61B 17/00C12M 47/04
70
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Systems and methods are described that are used to separate cells from a wide variety of tissues. In particular, automated systems and methods are described that separate regenerative cells, e.g., stem and/or progenitor cells, from adipose tissue. The systems and methods described herein provide rapid and reliable methods of separating and concentrating regenerative cells suitable for re-infusion into a subject.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . A tissue removal system for treating a patient, comprising:
 (a) a tissue collection container including:
 (i) a tissue collecting inlet port structured to receive adipose tissue removed from a patient; and 
 (ii) a filter disposed within the container and being structured to retain adipose tissue removed from a patient and to pass non-adipose tissue removed from the patient; 
   (b) a mixing container coupled to the tissue collection container to receive stem cells obtained from the adipose tissue without removal of the stem cells from the tissue removal system, and including an additive port for the administration of at least one additive to mix with the stem cells contained therein; and   (c) an outlet structured to permit the stem cells in the mixing container to be removed from the tissue collection system for administration to a patient.

Join the waitlist — get patent alerts

Track US2015152375A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.